Trial Profile
In combination therapy with insulin and DPP-4 inhibitor sitagliptin Study of efficacy and safety
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Feb 2013 New trial record